CONS BNY Mellon (US74907L4095)

(CONS) Notification on Corporate Action "Consent" - Quoin Pharmaceuticals, Ltd. ORD SHS ADR (depositary receipts ISIN US74907L4095)

Corporate Action Information
Corporate Action Reference	1171041
Corporate Action Type Code	CONS
Corporate Action Type	Consent
Mandatory Indicator	VOLU Voluntary

Security Details
Corporate Action Security Reference	Issuer	Security Name	Type of Financial Instrument	NSD Code	ISIN	Underlying Security Issuer	Underlying Security Type	Ratio ( Number of DR/ Number of Underlying Securities)
1171041D796	BNY Mellon	Quoin Pharmaceuticals, Ltd. ORD SHS ADR	American depository receipt	US74907L4095	US74907L4095	Quoin Pharmaceuticals, Ltd.	shares ordinary	1 : 35

Corporate Action Details
Record Date	01 may 2026

National Settlement Depository (NSD) notifies that the information regarding Consent has been received from International Settlement and Clearing Organization.
Detailed information regarding this corporate action event will be provided to holders who have balances of these securities on their safekeeping accounts with NSD.

If you have any questions related to this communication, please contact your account managers at NSD by telephone: +7 495 956-27-90 or +7 495 956-27-91.

Print page